Soy extracts versus hormone therapy for reduction of menopausal hot flushes: Indirect comparison

Menopause

Volumn 18, Issue 7, 2011, Pages 825-829

  Bolaños Díaz, Rafael ^a   Zavala Gonzales, Juan Carlos ^b   Mezones Holguín, Edward ^c,d   Francia Romero, José ^e  

^a UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^b HOSPITAL NACIONAL ARZOBISPO LOAYZA   (Peru)

^c INSTITUTO NACIONAL DE SALUD   (Peru)

^d UNIVERSIDAD PERUANA DE CIENCIAS APLICADAS   (Peru)

^e Instituto de Salud Integral BVida Plena   (Peru)

Author keywords

Hormone therapy; Hot flushes; Indirect comparison; Soy

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; FLAVONOID; GENISTEIN; ISOFLAVONE DERIVATIVE; MEDROXYPROGESTERONE; MESTRANOL; NORETHISTERONE ACETATE; PHYTOESTROGEN; PIPERAZINE ESTRONE SULFATE; PLACEBO; PLANT EXTRACT; SOY EXTRACT; UNCLASSIFIED DRUG;

CALCULATION; COMPARATIVE STUDY; DISEASE SEVERITY; DRUG EFFICACY; HORMONAL THERAPY; HOT FLUSH; HUMAN; MENOPAUSE; META ANALYSIS; POSTMENOPAUSE; REVIEW; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; THERAPY EFFECT;

ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HOT FLASHES; HUMANS; ISOFLAVONES; MENOPAUSE; META-ANALYSIS AS TOPIC; MIDDLE AGED; PLANT EXTRACTS; REFERENCE STANDARDS; SOYBEANS; STATISTICS AS TOPIC; THERAPEUTIC EQUIVALENCY; VASOMOTOR SYSTEM;

EID: 79959721585     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31820750bc     Document Type: Review

References (32)

1. Crisafulli A, Marini H, Bitto A, Altavilla D, Squadrito G, Romeo A. Effects of genistein on hot flushes in early postmenopausal women: a randomized, doubleYblind EPT-and placebo-controlled study. Menopause 2004;11:400-404. (Pubitemid 40372093)
2. Kaari C, Haidar MA, Júnior JM, et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 2006;53:49-58. (Pubitemid 41736059)
3. Howes L, Howes J, Knight D. Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 2006;55:203-211. (Pubitemid 44397351)
4. Bolaños R, Francia J. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis. Menopause 2010;17:660-666.
5. MacLennan A, Lester S, Moore V. Terapia de reemplazo estrogénico por vía oral versus placebo para el tratamiento de los sofocos. In: The Cochrane Library, Issue 2. Chichester, UK: John Wiley & Sons, Ltd, 2008.
6. Glenny A, Altman D, Song F, et al. Indirect comparisons of competing interventions. Health Technol Assess 2005;9:111-134.
7. Canadian Agency for Drugs and Technologies in Health. Indirect treatment comparisons in meta-analysis. Available at: http://www.cadth.ca/ media/pdf/H0462-itc-tr-e.pdf. Accessed March 2009.
8. Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms (Cochrane review). Cochrane Database Syst Rev 2007;CD001395 (last update, July 2007).
9. Krebs E, Ensrud K, MacDonald R, Wilt T. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004; 104:824-836. (Pubitemid 40458814)
10. Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057-2071. (Pubitemid 44794007)
11. Williamson-Hughes P, Flickinger B, Messina M, Empie M. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause 2006;13: 831-839. (Pubitemid 44435039)
12. Ferrari A. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. J Obstet Gynaecol Res 2009;35:1083-1090.
13. Borges A, Salazar V. Efecto de las isoflavonas de soya en el control de los síntomas peri-menopáusicos. Med Interna (Caracas) 2009;25:111-127.
14. Jadad A, Moher D, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995;16:62-73.
15. Khaodhiar L, Ricciotti H, Li L, et al. Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause 2008;15:125-132.
16. D'Anna R, Cannata ML, Atteritano M, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebocontrolled study. Menopause 2007;14:648-655. (Pubitemid 47051957)
17. Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soy extract containing isoflavones. Pharmacol Biochem Behav 2003;75:721-729. (Pubitemid 36936904)
18. Faure ED, Chantre P, Mares P. Effects of a standardised soy extract on hot flushes: a multicentre, double-blind, randomised placebo-controlled study. Menopause 2002;9:329-334. (Pubitemid 36701892)
19. Han KK, Soares JM, Haidar MA, Lima GR, Bacarat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002;99:389-394. (Pubitemid 34188398)
20. Penotti M, Fabio E, Modena AB, Rinaldi M, Omodei U, Vigano P. Effect of soy-derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertil Steril 2003;79: 1112-1117. (Pubitemid 36547847)
21. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: multicenter double-blind randomized placebocontrolled study. Menopause 2000;7:236-242. (Pubitemid 30445953)
22. Colacurci N, Zarcone R, Borrelli A, et al. Effects of soy on menopausal neurovegetative symptoms. Minerva Ginecol 2004;56:407-412. (Pubitemid 40039216)
23. Baerug U, Winge T, Nordland G, et al. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptomsi Climacteric 1998;1:219-228. (Pubitemid 128692284)
24. Bech P, Munk-Jensen N, Obel EB, Ulrich LG, Eiken P, Pors Nielsen S. Combined versus sequential hormonal replacement therapy: a doubleblind, placebo-controlled study on quality of life-related outcome measures. Psychother Psychosom 1998;67:259-265. (Pubitemid 28386471)
25. Blumel JE, Roncagliolo ME, Gramegna G, Vasquez R, Estartus AT. Double blind method of the effect of menopause symptoms, lipid profile, and endometrial thickness of continuous therapy with estradiol valerate and medroxyprogesterone acetate. Rev Chil Obstet Ginecol 1994;59:354-360.
26. Paterson ME. A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters. Maturitas 1982;4:83-94. (Pubitemid 12043766)
27. Chung TKH, Yip SK, Lam P, Chang AMZ, Haines CJ. A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms. Maturitas 1996;25:115-123. (Pubitemid 26336676)
28. Conard J, Basdevant A, Thomas J-L, et al. Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebocontrolled study with nomegestrol acetate and estradiol. Fertil Steril 1995;64:957-962.
29. Coope J, Thomson JM, Poller L. Effects of Bnatural oestrogen[ replacement therapy on menopausal symptoms and blood clotting. BMJ 1975; 4:139-143.
30. Coope J. Is oestrogen therapy effective in the treatment of menopausal depression? J R Coll Gen Pract 1981;31:134-140. (Pubitemid 11114716)
31. Derman RJ, Dawood MY, Stone S. Quality of life during sequential hormone replacement therapyVa placebo controlled study. Int J Fertil Menopausal Stud 1995;40:73-78.
32. Viklylaeva EM, Zaidiieva YaZ, Lobova TA, Shishkina AV, Larsen S. Trisequens in perimenopausal women with climacteric syndrome: a randomised double-blind trial. Acta Obstet Gynecol Scand 1997;76:58 (abstract P86.19).